Overview

Steroid Free Immunosuppression in Liver Transplantation

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether steroid-related complications can be avoided by using steroid-free immuno-suppressive drug regimen after liver transplantation.
Phase:
Phase 4
Details
Lead Sponsor:
Thomas Jefferson University
Collaborator:
Novartis Pharmaceuticals
Treatments:
Antibodies, Monoclonal
Basiliximab
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Mycophenolate mofetil
Mycophenolic Acid
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Prednisone
Tacrolimus